Logo image of MDT

MEDTRONIC PLC (MDT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MDT - IE00BTN1Y115 - Common Stock

98.63 USD
+0.15 (+0.15%)
Last: 12/19/2025, 8:04:00 PM
99.03 USD
+0.4 (+0.41%)
After Hours: 12/19/2025, 8:04:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MDT. MDT was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While MDT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MDT has a correct valuation and a medium growth rate. MDT also has an excellent dividend rating. This makes MDT very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MDT had positive earnings in the past year.
In the past year MDT had a positive cash flow from operations.
Each year in the past 5 years MDT has been profitable.
In the past 5 years MDT always reported a positive cash flow from operatings.
MDT Yearly Net Income VS EBIT VS OCF VS FCFMDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

The Return On Assets of MDT (5.22%) is better than 81.82% of its industry peers.
MDT's Return On Equity of 9.79% is amongst the best of the industry. MDT outperforms 85.56% of its industry peers.
MDT has a better Return On Invested Capital (6.63%) than 81.28% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MDT is below the industry average of 8.82%.
The last Return On Invested Capital (6.63%) for MDT is above the 3 year average (6.35%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.22%
ROE 9.79%
ROIC 6.63%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
MDT Yearly ROA, ROE, ROICMDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

MDT has a Profit Margin of 13.71%. This is amongst the best in the industry. MDT outperforms 89.84% of its industry peers.
MDT's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 19.42%, MDT belongs to the top of the industry, outperforming 93.05% of the companies in the same industry.
In the last couple of years the Operating Margin of MDT has remained more or less at the same level.
The Gross Margin of MDT (65.57%) is better than 69.52% of its industry peers.
In the last couple of years the Gross Margin of MDT has remained more or less at the same level.
Industry RankSector Rank
OM 19.42%
PM (TTM) 13.71%
GM 65.57%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
MDT Yearly Profit, Operating, Gross MarginsMDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MDT is still creating some value.
The number of shares outstanding for MDT has been reduced compared to 1 year ago.
The number of shares outstanding for MDT has been reduced compared to 5 years ago.
The debt/assets ratio for MDT is higher compared to a year ago.
MDT Yearly Shares OutstandingMDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
MDT Yearly Total Debt VS Total AssetsMDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

An Altman-Z score of 3.07 indicates that MDT is not in any danger for bankruptcy at the moment.
MDT has a better Altman-Z score (3.07) than 71.66% of its industry peers.
The Debt to FCF ratio of MDT is 5.59, which is a neutral value as it means it would take MDT, 5.59 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.59, MDT is doing good in the industry, outperforming 78.61% of the companies in the same industry.
MDT has a Debt/Equity ratio of 0.57. This is a neutral value indicating MDT is somewhat dependend on debt financing.
MDT's Debt to Equity ratio of 0.57 is on the low side compared to the rest of the industry. MDT is outperformed by 60.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.59
Altman-Z 3.07
ROIC/WACC1
WACC6.6%
MDT Yearly LT Debt VS Equity VS FCFMDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 2.42 indicates that MDT has no problem at all paying its short term obligations.
The Current ratio of MDT (2.42) is comparable to the rest of the industry.
MDT has a Quick Ratio of 1.80. This is a normal value and indicates that MDT is financially healthy and should not expect problems in meeting its short term obligations.
MDT has a Quick ratio of 1.80. This is comparable to the rest of the industry: MDT outperforms 47.59% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 1.8
MDT Yearly Current Assets VS Current LiabilitesMDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

4

3. Growth

3.1 Past

MDT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.24%.
The Earnings Per Share has been growing slightly by 3.68% on average over the past years.
MDT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.34%.
The Revenue has been growing slightly by 3.01% on average over the past years.
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%

3.2 Future

Based on estimates for the next years, MDT will show a small growth in Earnings Per Share. The EPS will grow by 6.35% on average per year.
MDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.79% yearly.
EPS Next Y3.61%
EPS Next 2Y5.98%
EPS Next 3Y6.33%
EPS Next 5Y6.35%
Revenue Next Year7.65%
Revenue Next 2Y6.74%
Revenue Next 3Y6.23%
Revenue Next 5Y5.79%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MDT Yearly Revenue VS EstimatesMDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
MDT Yearly EPS VS EstimatesMDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

MDT is valuated rather expensively with a Price/Earnings ratio of 17.52.
Compared to the rest of the industry, the Price/Earnings ratio of MDT indicates a rather cheap valuation: MDT is cheaper than 83.96% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.38, MDT is valued a bit cheaper.
MDT is valuated correctly with a Price/Forward Earnings ratio of 15.96.
Based on the Price/Forward Earnings ratio, MDT is valued cheaper than 86.63% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.83, MDT is valued a bit cheaper.
Industry RankSector Rank
PE 17.52
Fwd PE 15.96
MDT Price Earnings VS Forward Price EarningsMDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDT indicates a rather cheap valuation: MDT is cheaper than 82.35% of the companies listed in the same industry.
84.49% of the companies in the same industry are more expensive than MDT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.29
EV/EBITDA 14.33
MDT Per share dataMDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MDT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of MDT may justify a higher PE ratio.
PEG (NY)4.85
PEG (5Y)4.76
EPS Next 2Y5.98%
EPS Next 3Y6.33%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.88%, MDT has a reasonable but not impressive dividend return.
MDT's Dividend Yield is rather good when compared to the industry average which is at 0.19. MDT pays more dividend than 98.40% of the companies in the same industry.
MDT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 2.88%

5.2 History

The dividend of MDT has a limited annual growth rate of 5.10%.
MDT has been paying a dividend for at least 10 years, so it has a reliable track record.
MDT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.1%
Div Incr Years11
Div Non Decr Years11
MDT Yearly Dividends per shareMDT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

MDT pays out 75.86% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MDT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP75.86%
EPS Next 2Y5.98%
EPS Next 3Y6.33%
MDT Yearly Income VS Free CF VS DividendMDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
MDT Dividend Payout.MDT Dividend Payout, showing the Payout Ratio.MDT Dividend Payout.PayoutRetained Earnings

MEDTRONIC PLC

NYSE:MDT (12/19/2025, 8:04:00 PM)

After market: 99.03 +0.4 (+0.41%)

98.63

+0.15 (+0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-18 2025-11-18/bmo
Earnings (Next)02-17 2026-02-17/bmo
Inst Owners87.76%
Inst Owner Change0.47%
Ins Owners0.28%
Ins Owner Change3.79%
Market Cap126.44B
Revenue(TTM)34.76B
Net Income(TTM)4.76B
Analysts73.33
Price Target111.6 (13.15%)
Short Float %1.48%
Short Ratio2.75
Dividend
Industry RankSector Rank
Dividend Yield 2.88%
Yearly Dividend2.77
Dividend Growth(5Y)5.1%
DP75.86%
Div Incr Years11
Div Non Decr Years11
Ex-Date12-26 2025-12-26 (0.71)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.96%
Min EPS beat(2)1.49%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.68%
Min EPS beat(4)1.21%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.26%
EPS beat(12)9
Avg EPS beat(12)1.96%
EPS beat(16)10
Avg EPS beat(16)1.24%
Revenue beat(2)2
Avg Revenue beat(2)0.49%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.91%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.29%
Revenue beat(12)10
Avg Revenue beat(12)0.59%
Revenue beat(16)11
Avg Revenue beat(16)-0.1%
PT rev (1m)8.34%
PT rev (3m)10.98%
EPS NQ rev (1m)-0.85%
EPS NQ rev (3m)-1.13%
EPS NY rev (1m)0.29%
EPS NY rev (3m)0.51%
Revenue NQ rev (1m)0.46%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE 17.52
Fwd PE 15.96
P/S 3.64
P/FCF 24.29
P/OCF 17.78
P/B 2.6
P/tB N/A
EV/EBITDA 14.33
EPS(TTM)5.63
EY5.71%
EPS(NY)6.18
Fwd EY6.26%
FCF(TTM)4.06
FCFY4.12%
OCF(TTM)5.55
OCFY5.63%
SpS27.11
BVpS37.95
TBVpS-3.06
PEG (NY)4.85
PEG (5Y)4.76
Graham Number69.34
Profitability
Industry RankSector Rank
ROA 5.22%
ROE 9.79%
ROCE 8.29%
ROIC 6.63%
ROICexc 7.39%
ROICexgc 26.33%
OM 19.42%
PM (TTM) 13.71%
GM 65.57%
FCFM 14.98%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.59
Debt/EBITDA 2.83
Cap/Depr 63.21%
Cap/Sales 5.49%
Interest Coverage 8.53
Cash Conversion 72.83%
Profit Quality 109.28%
Current Ratio 2.42
Quick Ratio 1.8
Altman-Z 3.07
F-Score8
WACC6.6%
ROIC/WACC1
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
EPS Next Y3.61%
EPS Next 2Y5.98%
EPS Next 3Y6.33%
EPS Next 5Y6.35%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
Revenue Next Year7.65%
Revenue Next 2Y6.74%
Revenue Next 3Y6.23%
Revenue Next 5Y5.79%
EBIT growth 1Y7.35%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year16.81%
EBIT Next 3Y10.65%
EBIT Next 5Y9.23%
FCF growth 1Y28.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y27.68%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%

MEDTRONIC PLC / MDT FAQ

What is the ChartMill fundamental rating of MEDTRONIC PLC (MDT) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MDT.


Can you provide the valuation status for MEDTRONIC PLC?

ChartMill assigns a valuation rating of 6 / 10 to MEDTRONIC PLC (MDT). This can be considered as Fairly Valued.


How profitable is MEDTRONIC PLC (MDT) stock?

MEDTRONIC PLC (MDT) has a profitability rating of 8 / 10.


What are the PE and PB ratios of MEDTRONIC PLC (MDT) stock?

The Price/Earnings (PE) ratio for MEDTRONIC PLC (MDT) is 17.52 and the Price/Book (PB) ratio is 2.6.


Can you provide the financial health for MDT stock?

The financial health rating of MEDTRONIC PLC (MDT) is 6 / 10.